Literature DB >> 16926138

X-linked agammaglobulinemia diagnosed in adulthood: a case report.

Takeki Mitsui1, Norifumi Tsukamoto, Hirokazu Kanegane, Kazunaga Agematsu, Tomomi Sekigami, Hiroyuki Irisawa, Takayuki Saitoh, Hideki Uchiumi, Hiroshi Handa, Takafumi Matsushima, Masamitsu Karasawa, Hirokazu Murakami, Toshio Miyawaki, Yoshihisa Nojima.   

Abstract

X-linked agammaglobulinemia (XLA) is a humoral immunodeficiency caused by mutations in Bruton's tyrosine kinase (BTK). Patients typically become symptomatic during infancy or early childhood and develop recurrent bacterial infections. We report a Japanese case of XLA diagnosed in a patient who was 27 years of age and who had no history of severe infection. The patient's serum immunoglobulin (Ig) G, IgA, and IgM levels were 132,7, and 17 mg/dL, respectively. The percentage of positive cells for CD19 and CD20 was 0.03% and 0.02%, respectively. The patient's brother and sister had no abnormalities. Flow cytometric analysis showed a partially reduced expression of BTK protein in the patient's peripheral monocytes. Sequencing of the BTK. gene revealed a missense mutation (230C>T,T33I). Given this data, this patient was diagnosed as having rare, late onset XLA with a missense mutation in the BTK gene.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16926138     DOI: 10.1532/IJH97.06095

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  24 in total

Review 1.  Bruton's tyrosine kinase: cell biology, sequence conservation, mutation spectrum, siRNA modifications, and expression profiling.

Authors:  Jessica M Lindvall; K Emelie M Blomberg; Jouni Väliaho; Leonardo Vargas; Juhana E Heinonen; Anna Berglöf; Abdalla J Mohamed; Beston F Nore; Mauno Vihinen; C I Edvard Smith
Journal:  Immunol Rev       Date:  2005-02       Impact factor: 12.988

2.  Agammaglobulinemia.

Authors:  O C BRUTON
Journal:  Pediatrics       Date:  1952-06       Impact factor: 7.124

3.  Brief report: a point mutation in the SH2 domain of Bruton's tyrosine kinase in atypical X-linked agammaglobulinemia.

Authors:  D C Saffran; O Parolini; M E Fitch-Hilgenberg; D J Rawlings; D E Afar; O N Witte; M E Conley
Journal:  N Engl J Med       Date:  1994-05-26       Impact factor: 91.245

Review 4.  X-linked agammaglobulinemia: an analysis of 96 patients.

Authors:  H M Lederman; J A Winkelstein
Journal:  Medicine (Baltimore)       Date:  1985-05       Impact factor: 1.889

5.  Detection of Bruton's tyrosine kinase mutations in hypogammaglobulinaemic males registered as common variable immunodeficiency (CVID) in the Japanese Immunodeficiency Registry.

Authors:  H Kanegane; S Tsukada; T Iwata; T Futatani; K Nomura; J Yamamoto; T Yoshida; K Agematsu; A Komiyama; T Miyawaki
Journal:  Clin Exp Immunol       Date:  2000-06       Impact factor: 4.330

6.  Atypical X-linked agammaglobulinemia diagnosed in three adults.

Authors:  S Hashimoto; T Miyawaki; T Futatani; H Kanegane; K Usui; T Nukiwa; S Namiuchi; M Matsushita; T Yamadori; M Suemura; T Kishimoto; S Tsukada
Journal:  Intern Med       Date:  1999-09       Impact factor: 1.271

7.  Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies).

Authors:  M E Conley; L D Notarangelo; A Etzioni
Journal:  Clin Immunol       Date:  1999-12       Impact factor: 3.969

8.  Deficient expression of Bruton's tyrosine kinase in monocytes from X-linked agammaglobulinemia as evaluated by a flow cytometric analysis and its clinical application to carrier detection.

Authors:  T Futatani; T Miyawaki; S Tsukada; S Hashimoto; T Kunikata; S Arai; M Kurimoto; Y Niida; H Matsuoka; Y Sakiyama; T Iwata; S Tsuchiya; O Tatsuzawa; K Yoshizaki; T Kishimoto
Journal:  Blood       Date:  1998-01-15       Impact factor: 22.113

9.  The gene involved in X-linked agammaglobulinaemia is a member of the src family of protein-tyrosine kinases.

Authors:  D Vetrie; I Vorechovský; P Sideras; J Holland; A Davies; F Flinter; L Hammarström; C Kinnon; R Levinsky; M Bobrow
Journal:  Nature       Date:  1993-01-21       Impact factor: 49.962

10.  Deficient expression of a B cell cytoplasmic tyrosine kinase in human X-linked agammaglobulinemia.

Authors:  S Tsukada; D C Saffran; D J Rawlings; O Parolini; R C Allen; I Klisak; R S Sparkes; H Kubagawa; T Mohandas; S Quan
Journal:  Cell       Date:  1993-01-29       Impact factor: 41.582

View more
  3 in total

Review 1.  Common variable immunodeficiency: etiological and treatment issues.

Authors:  Sean Deane; Carlo Selmi; Stanley M Naguwa; Suzanne S Teuber; M Eric Gershwin
Journal:  Int Arch Allergy Immunol       Date:  2009-07-01       Impact factor: 2.749

2.  Placental transfer of maternally-derived IgA precludes the use of guthrie card eluates as a screening tool for primary immunodeficiency diseases.

Authors:  Stephan Borte; Magdalena Janzi; Qiang Pan-Hammarström; Ulrika von Döbeln; Lennart Nordvall; Jacek Winiarski; Anders Fasth; Lennart Hammarström
Journal:  PLoS One       Date:  2012-08-16       Impact factor: 3.240

3.  X-linked agammaglobulinemia diagnosed late in life: case report and review of the literature.

Authors:  Justin R Sigmon; Ehab Kasasbeh; Guha Krishnaswamy
Journal:  Clin Mol Allergy       Date:  2008-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.